Experimental weight loss drug could help treat fatty liver disease in people with obesity, study finds
Fox News
The experimental weight loss drug retatrutide could also help to improve liver health, a new study suggests. The findings came from a large clinical trialled by Virginia Commonwealth University.
Researchers found that the injectable drug decreased fat in people's livers to the point that they would no longer be classified as having fatty liver disease, according to study lead Dr. Arun Sanyal, M.D., a hepatologist who is director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health. "Now we could have a treatment that allows you to wipe out the liver fat in patients with early-stage liver disease." Amy McGorry is a contributing health writer for Fox News Digital. Follow her on Twitter @amymcgorry.
The findings were shared on Nov. 13 at a meeting of the American Association for the Study of Liver Diseases in Boston.